Deleted Tweets From Scott Gottlieb, R-D.C.

We saw a 4-fold increase in novel device approvals in 2017, thanks to our streamlined clinical development protocols without compromising on commitment to rely on rigorous evidence as FDA’s gold standard for assuring device safety & effectiveness. #SO

#FDA set a modern record number of novel drugs and biologics approved in 2017, plus two all-time records with 56 breakthrough designations assigned on pipeline drugs and 82 priority reviews granted. This all reflects a very robust scientific pipeline. #SO

1st ever gene therapy approvals in 2017 for patients with serious and rare diseases. I believe gene therapy will eventually become a mainstay therapeutic approach in treating, and maybe curing, some of our most devastating illnesses #SOTU #genetherapy htt

RT @FDATobacco: #FACT: Modern cigarettes deliver #nicotine more quickly from the lungs to the brain, making them more addictive tha… https://t.co/c0tcCQkJjd

Today #FDA hosted an online tutorial about the new FAERS dashboard, which provides the public with easier access to adverse event data submitted to FDA: https://t.co/TdyOuXRKS1

RT @UPIPhotos: FDA Commissioner Scott Gottlieb and USDA Secretary Sonny Perdue sign a formal agreement between the USDA and HHS re… https://t.co/n2B7Y89XiM

Day 2 of the #FDAPrecert conference! Group breakout sessions today—looking forward to really productive feedback. Remember, the public is the 10th participant in our pilot. #digitalhealth @_bakulpatel @FDAcdrhIndustry

#FDA took a fairly unprecedented action by asking makers of over-the-counter loperamide to change how it’s packaged as a way to help address a growing problem of abuse and misuse. Packaging is a critical tool we aim to use in addressing the opioid crisis

More than 1,300 people registered for today’s #FDA tutorial on the new FAERS dashboard. The webinar provides an overview of the benefits and limitations of FAERS data. The recording will be available on https://t.co/VDDgD2ZTe6: https://t.co/TdyOuXRKS1

#FDA Law Blog on Joint Action by #FDA and #FTC Against Companies Marketing Unapproved Opioid Cessation Products - https://t.co/FNwvCwBmbd

RT @US_FDA: FDA taking new steps to help prevent new addiction, curb abuse and overdose related to opioid products.… https://t.co/kG6HQqFQ9t

FDA food program starts accepting applications TODAY for #VQIP (Voluntary Qualified Importer Program). Questions about the benefits? We’ve got answers for importers of FDA-regulated human and/or animal food. https://t.co/zGyaUBZ5cD

RT @FDADeviceInfo: Bakul Patel talks modernizing regulatory structures while preserving standards of safety and effectiveness for… https://t.co/395sgaRISe

In 2017, @FDAOncology approved 17 new drug and biologic applications, 32 supplemental drug and biologic applications, and two biosimilar applications in oncology https://t.co/5q4ubyYK1X… #OCEpub

FDA Announces Public Mtg on Best Practices in Modeling and Simulation for Oncology Products - https://t.co/4DhPLTrD49

@cdc We’re optimistic saline supplies will continue improving, but we recognize that rising demand may continue to strain availability, even as production and supply continues to grow.

Our new update on #FDA’s work monitoring flu activity w/ @CDC and our steps to ensure flu patients have access to critical medical products, incl. antivirals, saline and other supportive care drugs and devices. We will continue to provide updates https://

RT @FDAMedia: Statement from @SGottliebFDA on ongoing efforts to mitigate impact of saline shortages during this flu season: https://t.co/aBjON7FBPh

RT @NatureBiotech: On our blog, @US_FDA commissioner @SGottliebFDA talks further with @CT_Morrison about #drugprices, competition and… https://t.co/mANqeSPDis

While there have been some reported spot shortages, flu vaccines are still available. I strongly encourage anyone who hasn’t had a flu shot to get one and anyone experiencing flu-like symptoms promptly consult their health care provider about appropriate

We saw a 4-fold increase in novel device approvals in 2017, thanks to our streamlined clinical development protocols without compromising on commitment to rely on rigorous evidence as FDA’s gold standard for assuring device safety & effectiveness. #SO

#FDA set a modern record number of novel drugs and biologics approved in 2017, plus two all-time records with 56 breakthrough designations assigned on pipeline drugs and 82 priority reviews granted. This all reflects a very robust scientific pipeline. #SO

1st ever gene therapy approvals in 2017 for patients with serious and rare diseases. I believe gene therapy will eventually become a mainstay therapeutic approach in treating, and maybe curing, some of our most devastating illnesses #SOTU #genetherapy htt

RT @FDATobacco: #FACT: Modern cigarettes deliver #nicotine more quickly from the lungs to the brain, making them more addictive tha… https://t.co/c0tcCQkJjd

Today #FDA hosted an online tutorial about the new FAERS dashboard, which provides the public with easier access to adverse event data submitted to FDA: https://t.co/TdyOuXRKS1

RT @UPIPhotos: FDA Commissioner Scott Gottlieb and USDA Secretary Sonny Perdue sign a formal agreement between the USDA and HHS re… https://t.co/n2B7Y89XiM

Day 2 of the #FDAPrecert conference! Group breakout sessions today—looking forward to really productive feedback. Remember, the public is the 10th participant in our pilot. #digitalhealth @_bakulpatel @FDAcdrhIndustry

#FDA took a fairly unprecedented action by asking makers of over-the-counter loperamide to change how it’s packaged as a way to help address a growing problem of abuse and misuse. Packaging is a critical tool we aim to use in addressing the opioid crisis

More than 1,300 people registered for today’s #FDA tutorial on the new FAERS dashboard. The webinar provides an overview of the benefits and limitations of FAERS data. The recording will be available on https://t.co/VDDgD2ZTe6: https://t.co/TdyOuXRKS1

#FDA Law Blog on Joint Action by #FDA and #FTC Against Companies Marketing Unapproved Opioid Cessation Products - https://t.co/FNwvCwBmbd

RT @US_FDA: FDA taking new steps to help prevent new addiction, curb abuse and overdose related to opioid products.… https://t.co/kG6HQqFQ9t

FDA food program starts accepting applications TODAY for #VQIP (Voluntary Qualified Importer Program). Questions about the benefits? We’ve got answers for importers of FDA-regulated human and/or animal food. https://t.co/zGyaUBZ5cD

RT @FDADeviceInfo: Bakul Patel talks modernizing regulatory structures while preserving standards of safety and effectiveness for… https://t.co/395sgaRISe

In 2017, @FDAOncology approved 17 new drug and biologic applications, 32 supplemental drug and biologic applications, and two biosimilar applications in oncology https://t.co/5q4ubyYK1X… #OCEpub

FDA Announces Public Mtg on Best Practices in Modeling and Simulation for Oncology Products - https://t.co/4DhPLTrD49

@cdc We’re optimistic saline supplies will continue improving, but we recognize that rising demand may continue to strain availability, even as production and supply continues to grow.

Our new update on #FDA’s work monitoring flu activity w/ @CDC and our steps to ensure flu patients have access to critical medical products, incl. antivirals, saline and other supportive care drugs and devices. We will continue to provide updates https://

RT @FDAMedia: Statement from @SGottliebFDA on ongoing efforts to mitigate impact of saline shortages during this flu season: https://t.co/aBjON7FBPh

RT @NatureBiotech: On our blog, @US_FDA commissioner @SGottliebFDA talks further with @CT_Morrison about #drugprices, competition and… https://t.co/mANqeSPDis

While there have been some reported spot shortages, flu vaccines are still available. I strongly encourage anyone who hasn’t had a flu shot to get one and anyone experiencing flu-like symptoms promptly consult their health care provider about appropriate